VVOS

Healthcare Medical Devices

Vivos Therapeutics, Inc.

$0.15

+0.01 +3.83% today

Price History

Not enough data

Key Stats

Market Cap

3.06M

Avg Volume

12.53M

EPS

-$1.88

52W High

$3.42

52W Low

$0.13

Div. Yield

0.0%

Analyst Ratings

Buy

Str Buy

Buy

Hold

Sell

Str Sell

Valuation

Forward P/E

-0.18

P/B Ratio

-0.45

P/S Ratio

0.15

EV/EBITDA

-0.71

EV/Revenue

0.70

Margins

Gross Margin 61.9%

Operating Margin (93.6%)

Net Margin (121.8%)

EBITDA Margin (99.3%)

Growth & Returns

Revenue Growth (YoY)

34.9%

Return on Equity

(8585.3%)

Return on Assets

(56.2%)

Liquidity & Leverage

Current Ratio

0.21

Quick Ratio

0.16

Total Cash

1.77M

Total Debt

12.51M

About

Vivos Therapeutics, Inc. operates as a medical technology and healthcare services company that develops and commercializes treatment modalities for patients with dentofacial abnormalities, obstructive sleep apnea (OSA), and snoring in adults. It offers The Vivos Method, a non-invasive, non-surgical, non-pharmaceutical, multi-disciplinary treatment modality for the treatment of dentofacial abnormalities, OSA, and snoring. The company also offers VivoScore Program, a screening and home sleep test in adults and children. It markets and sells its appliances, and related treatments and services to licensed professionals, primarily general dentists in the United States and Canada. The company was formerly known as Vivos BioTechnologies, Inc. and changed its name to Vivos Therapeutics, Inc. in March 2018. The company was founded in 2016 and is based in Littleton, Colorado.